Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Shackleton

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Angiogenesis|June 25, 2016
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesisLisa M Ebert, Lih Y Tan, M Zahied Johan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 29, 2024
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanomaRoderick F O'Day, R Max Conway, Li-Anne Lim, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
BMC Cancer|January 29, 2025
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary originAnna Ugalde, Richard W Tothill, Stephen Quinn, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
British Journal of Cancer|October 22, 2020
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysisPrachi Bhave, Lalit Pallan, Georgina V Long, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Nature Communications|March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingIsmael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Angiogenesis|June 25, 2016
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesisLisa M Ebert, Lih Y Tan, M Zahied Johan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 29, 2024
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanomaRoderick F O'Day, R Max Conway, Li-Anne Lim, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
BMC Cancer|January 29, 2025
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary originAnna Ugalde, Richard W Tothill, Stephen Quinn, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
British Journal of Cancer|October 22, 2020
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysisPrachi Bhave, Lalit Pallan, Georgina V Long, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Nature Communications|March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingIsmael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Pageof 10